Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Key role of phosphodiesterase 4A (PDE4A) in autophagy triggered by yessotoxin
A Fernández-Araujo1, A Alfonso1, M R Vieytes2
1Dept. Farmacología, Facultad de Veterinaria, 27002 Lugo, Spain.
Abstract:
Understanding the mechanism of action of the yessotoxin (YTX) is crucial since this drug has potential pharmacological effects in allergic processes, tumor proliferation and neurodegenerative diseases. It has been described that YTX activates apoptosis after 24h of treatment, while after 48 h of incubation with the toxin a decrease in cell viability corresponding to cellular differentiation or non-apoptotic cell death was observed. In this paper, these processes were extensively studied by using the erythroleukemia K-562 cell line. On one hand, events of K-562 cell differentiation into erythrocytes after YTX treatment were studied using hemin as positive control of cell differentiation. Cell differentiation was studied through the cyclic nucleotide response element binding (phospho-CREB) and the transferrin receptor (TfR) expression. On the other hand, using rapamycin as positive control, autophagic hallmarks, as non-apoptotic cell death, were studied after toxin exposure. In this case, the mechanistic target of rapamycin (mTOR) and light chain 3B (LC3B) levels were measured to check autophagy activation. The results showed that cell differentiation was not occurring after 48 h of toxin incubation while at this time the autophagy was triggered. Furthermore after 24h of toxin treatment none of these processes were activated. In addition, the role of the type 4A phosphodiesterase (PDE4A), the intracellular target of YTX, was checked. PDE4A-silencing experiments showed different regulation steps of PDE4A in the autophagic processes triggered either by traditional compounds or YTX. In summary, after 48 h YTX treatment PDE4A-dependent autophagy, as non-apoptotic programmed cell death, is activated.
Insights
Yessotoxin (YTX) treatment activates PDE4A-dependent autophagy, a form of programmed cell death, after 48 hours. This mechanism, crucial for understanding YTX
Area of Science:
- Pharmacology and Toxicology
- Cell Biology
- Molecular Mechanisms
Background:
- Yessotoxin (YTX) exhibits potential pharmacological effects in allergic processes, tumor proliferation, and neurodegenerative diseases.
- Previous studies indicated YTX activates apoptosis at 24h and causes decreased cell viability via differentiation or non-apoptotic cell death at 48h.
- The precise mechanisms underlying YTX's cellular effects require further elucidation.
Purpose of the Study:
- To investigate the cellular mechanisms of YTX action, specifically differentiating between apoptosis, cell differentiation, and non-apoptotic cell death.
- To elucidate the role of type 4A phosphodiesterase (PDE4A) in YTX-induced cellular responses.
- To determine the specific cellular processes activated by YTX at 24h and 48h time points.
Main Methods:
- Utilized the erythroleukemia K-562 cell line for experiments.
- Assessed cell differentiation markers including cyclic nucleotide response element binding (phospho-CREB) and transferrin receptor (TfR) expression, with hemin as a positive control.
- Evaluated autophagic hallmarks, indicative of non-apoptotic cell death, by measuring mechanistic target of rapamycin (mTOR) and light chain 3B (LC3B) levels, using rapamycin as a positive control.
- Performed PDE4A-silencing experiments to investigate its regulatory role in autophagy.
Main Results:
- Cell differentiation was not observed after 48h of YTX incubation.
- Autophagy was triggered at 48h of YTX treatment.
- No significant activation of apoptosis, differentiation, or autophagy was detected at 24h of YTX treatment.
- PDE4A-silencing experiments revealed distinct regulatory roles of PDE4A in YTX-induced autophagy compared to traditional autophagy-inducing compounds.
- YTX treatment at 48h activates PDE4A-dependent autophagy, characterized as non-apoptotic programmed cell death.
Conclusions:
- YTX induces non-apoptotic programmed cell death via autophagy at 48h of treatment.
- Cellular differentiation is not the primary outcome of YTX exposure at 48h.
- The intracellular target PDE4A plays a critical role in mediating YTX-induced autophagy.
More Related Videos
09:34The Lactate Dehydrogenase Sequestration Assay — A Simple and Reliable Method to Determine Bulk Autophagic Sequestration Activity in Mammalian Cells
Published on: July 27, 2018
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Cellular Injury V: Apoptosis and Autophagy
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...